Holmes–Benacerraf syndrome
Holmes–Benacerraf syndrome is a rare genetic disorder characterized by a combination of congenital anomalies. The syndrome was first described by Holmes and Benacerraf, after whom it is named. It is a condition that presents a significant challenge in terms of diagnosis and management due to its rarity and the complexity of its presentation.
Symptoms and Signs[edit | edit source]
The clinical manifestations of Holmes–Benacerraf syndrome can vary significantly among affected individuals. However, common features include congenital heart defects, skeletal abnormalities, and growth retardation. Patients may also exhibit facial dysmorphisms, such as a cleft palate or lip, and intellectual disability.
Causes[edit | edit source]
Holmes–Benacerraf syndrome is believed to be caused by genetic mutations. The exact genetic mechanism and the specific genes involved have not been fully elucidated. It is thought to follow an autosomal recessive inheritance pattern, where both parents must carry a copy of the mutated gene to pass the disorder onto their children.
Diagnosis[edit | edit source]
Diagnosis of Holmes–Benacerraf syndrome is primarily based on clinical evaluation and the identification of characteristic physical anomalies. Genetic testing may be helpful in confirming the diagnosis, especially in cases where the genetic basis of the syndrome has been identified. Prenatal diagnosis through ultrasound and genetic testing of fetal DNA may also be possible in families with a known history of the syndrome.
Treatment[edit | edit source]
There is no cure for Holmes–Benacerraf syndrome. Treatment is symptomatic and supportive, focusing on managing the individual symptoms and preventing complications. This may include surgical interventions for congenital heart defects or skeletal abnormalities, special educational services for intellectual disability, and other therapies aimed at improving the quality of life of affected individuals.
Prognosis[edit | edit source]
The prognosis for individuals with Holmes–Benacerraf syndrome varies depending on the severity of the symptoms and the presence of life-threatening congenital anomalies. Early diagnosis and intervention can improve the outcome for some patients, but the syndrome can significantly impact life expectancy and quality of life.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD